Invention Grant
- Patent Title: Tumor-specific recognition molecules
- Patent Title (中): 肿瘤特异性识别分子
-
Application No.: US10536834Application Date: 2003-12-01
-
Publication No.: US08088357B2Publication Date: 2012-01-03
- Inventor: Steffen Goletz , Antje Danielczyk , Uwe Karsten , Peter Ravn , Renate Stahn , Peter Astrup Christensen
- Applicant: Steffen Goletz , Antje Danielczyk , Uwe Karsten , Peter Ravn , Renate Stahn , Peter Astrup Christensen
- Applicant Address: DE Berlin
- Assignee: Nemod Biotherapeutics GmbH & Co. KG
- Current Assignee: Nemod Biotherapeutics GmbH & Co. KG
- Current Assignee Address: DE Berlin
- Agency: Fanelli Haag PLLC
- Priority: DE10256900 20021129
- International Application: PCT/DE03/03994 WO 20031201
- International Announcement: WO2004/050707 WO 20040617
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C07K16/30 ; G01N33/574 ; G01N33/577
Abstract:
The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.
Public/Granted literature
- US20060251668A1 Tumor-specific recognition molecules Public/Granted day:2006-11-09
Information query
